Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 92 Polycystic Ovary Syndrome 11 Neoplasm Metastasis 7 Infertility 5 Carcinoma, Ductal, Breast 5 Carcinoma, Lobular 4 Osteoporosis 3 Neoplasms, Hormone-Dependent 3 Neoplasms 3 Breast Neoplasms, Male 3 Advanced Breast Cancer 3 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Carcinoma In Situ 2 Bone Diseases, Metabolic 2 Unilateral Breast Neoplasms 1 Recurrence 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Osteitis Deformans 1 Obesity 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1 Low Grade Serous Ovarian Cancer 1 Infertility, Female 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Hereditary Breast and Ovarian Cancer Syndrome 1 HR+/HER2- Breast Cancer 1 HER2+ Breast Cancer 1

Interventions

fluzoparib 1 exemestane 1 dalpiciclib 1 Trastuzumab 1 Letrozole 1 Ga(III)-DOTATOC 1 Everolimus 1 Docetaxel 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Cancer Metastatic × Letrozole × Clear all

NCT02511639 2020-12-03

MAIN-A

Istituto Oncologico Veneto IRCCS

Phase 3 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡